Upping the antedrug: Is a novel anti-inflammatory Toll-like receptor 7 agonist also a bronchodilator?

British Journal of Pharmacology

Volumn 166, Issue 2, 2012, Pages 569-572

  Kaufman, E H ^a   Jacoby, D B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

allergy; antedrug; asthma; bronchodilator; immunomodulator; inflammation; Toll like receptor 7

Indexed keywords

8 OXOADENINE DERIVATIVE; ADENINE DERIVATIVE; ANTEDRUG; AZ 12441970; DRUG; GUANOSINE DERIVATIVE; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; OLIGONUCLEOTIDE; RESIQUIMOD; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 7 AGONIST; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DRUG EXPOSURE; DRUG METABOLISM; DRUG POTENCY; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH1 CELL; TH2 CELL; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; HUMANS; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY; TOLL-LIKE RECEPTOR 7;

EID: 84859904767     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01758.x     Document Type: Review

References (26)

1. Bian T, Yin KS, Jin SX, Zhang XL, Zhou JY, Ma XQ, et al,. (2006). Treatment of allergic airway inflammation and hyperresponsiveness by imiquimod modulating transcription factors T-bet and GATA-3. Chin Med J (Engl) 119: 640-648. (Pubitemid 43796844)
2. Biffen M, Matsui H, Edwards S, Leishman AJ, Eiho K, Holness E, et al,. (2012). Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity. Br J Pharmacol 166: 573-586.
3. Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, Marion D, et al,. (2007). Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 175: 1241-1249. (Pubitemid 46905749)
4. Camateros P, Kanagaratham C, Henri J, Sladek R, Hudson TJ, Radzioch D, (2009). Modulation of the allergic asthma transcriptome following resiquimod treatment. Physiol Genomics 38: 303-318.
5. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, An SS, et al,. (2010). Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 16: 1299-1304.
6. Diebold SS, (2008). Recognition of viral single-stranded RNA by Toll-like receptors. Adv Drug Deliv Rev 60: 813-823.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C, (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. (Pubitemid 38314425)
8. Duechs MJ, Hahn C, Benediktus E, Werner-Klein M, Braun A, Hoymann HG, et al,. (2011). TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm Pharmacol Ther 24: 203-214.
9. Ekman AK, Adner M, Cardell LO, (2010). Toll-like receptor 7 activation reduces the contractile response of airway smooth muscle. Eur J Pharmacol 652: 145-151.
10. Fidock MD, Souberbielle BE, Laxton C, Rawal J, Delpuech-Adams O, Corey TP, et al,. (2011). The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691). Clin Pharmacol Ther 89: 821-829.
11. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al,. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200. (Pubitemid 34141451)
12. Jin SX, Yin KS, Bian T, Sun PL, (2006). Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice. Chin Med J (Engl) 119: 412-416. (Pubitemid 43796897)
13. Kaufman EH, Fryer AD, Jacoby DB, (2011). Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs. J Allergy Clin Immunol 127: 462-469.
14. Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA, et al,. (2003). Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A 100: 6646-6651. (Pubitemid 36666635)
15. Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, et al,. (2006). Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A 103: 1828-1833. (Pubitemid 43228778)
16. Meng L, He X, Zhu W, Yang X, Jiang C, Sun Q, et al,. (2011). TLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organs. PLoS ONE 6: e17252.
17. Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, Martin P, et al,. (2006). TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 290: L987-L995. (Pubitemid 43725061)
18. Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, McHutchison JG, et al,. (2007). Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. J Hepatol 47: 174-182. (Pubitemid 47021257)
19. Quarcoo D, Weixler S, Joachim RA, Stock P, Kallinich T, Ahrens B, et al,. (2004). Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin Exp Allergy 34: 1314-1320. (Pubitemid 39093074)
20. Schon MP, Schon M, Klotz KN, (2006). The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126: 1338-1347. (Pubitemid 43997917)
21. Seiler S, Gillespie E, Arnold AJ, Brassard CL, Meanwell NA, Fleming JS, (1991). Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets. Thromb Res 62: 31-42.
22. Sel S, Wegmann M, Bauer S, Garn H, Alber G, Renz H, (2007). Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 178: 7805-7813. (Pubitemid 46898052)
23. Stokes JR, Sorkness RL, Kaplan MR, Castleman WL, Tomai MA, Miller RL, et al,. (1998). Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur Respir J 11: 324-329. (Pubitemid 28108343)
24. Van LP, Bardel E, Gregoire S, Vanoirbeek J, Schneider E, Dy M, et al,. (2011). Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms. Eur J Immunol 41: 1992-1999.
25. Vultaggio A, Nencini F, Fitch PM, Fili L, Maggi L, Fanti P, et al,. (2009). Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. J Immunol 182: 880-889.
26. Xirakia C, Koltsida O, Stavropoulos A, Thanassopoulou A, Aidinis V, Sideras P, et al,. (2010). Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 181: 1207-1216.